Stocks in Play

Lorus Therapeutics Inc.

09:51 AM EST - Lorus Therapeutics Inc. : announced that the Canadian Intellectual Property Office has issued Lorus' patent for its cancer immunotherapy agent, IL-17E. Lorus Therapeutics Inc.
shares T.LOR are trading up $0.03 at $0.50.